STORM trial to identify genetic variability in metastatic breast cancer
9 Sep 2017
STORM trial to identify genetic variability in metastatic breast cancer
The UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer
STAMPEDE: Abiraterone acetate plus prednisolone or docetaxel
Problems with care: a patients perspective
Reduced work ability in cancer survivors
Problems with survivorship care in Europe
Underprovision and inequality of specialised cancer care
Regorafenib versus lomustine for relapsed glioblastoma
Reviewing LORELEI, mindACT and ExteNET trials in breast cancer
Questioning the role of CT-scan in NSCLC post-surgery follow-up
Osimertinib suitable for first line EGFRm lung cancer
FLAURA study of osimertinib versus TKI for 1st line NSCLC